^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    KDR expression

    i
    Other names: VEGFR2, KDR, Vascular Endothelial Growth Factor Receptor 2, Protein-Tyrosine Kinase Receptor Flk-1, Fetal Liver Kinase 1, FLK1, CD309, CD309 Antigen
    Entrez ID:
    3791
    Related biomarkers:
    Expression
    Mutation
    CNA
    Others
    Apply
    BR55 in Prostate Cancer: an Exploratory Clinical Trial (NCT01253213)
    Phase 1
    Bracco Diagnostics, Inc
    Completed
    Last update posted :
    08/01/2023
    Initiation :
    07/01/2010
    Primary completion :
    12/01/2012
    Completion :
    12/01/2012
    KDR
    |
    KDR expression
    Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT04547088)
    Phase 2
    Sun Yat-sen University
    Not yet recruiting
    Last update posted :
    09/14/2020
    Initiation :
    09/01/2020
    Primary completion :
    10/01/2022
    Completion :
    10/01/2023
    PD-L1 • KDR
    |
    PD-L1 expression • KDR expression
    |
    AiRuiKa (camrelizumab) • AiTan (rivoceranib)
    Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT04548271)
    Phase 2
    Sun Yat-sen University
    Not yet recruiting
    Last update posted :
    09/14/2020
    Initiation :
    09/01/2020
    Primary completion :
    10/01/2022
    Completion :
    10/01/2023
    PD-L1 • KDR
    |
    PD-L1 expression • KDR expression
    |
    AiRuiKa (camrelizumab) • AiTan (rivoceranib)
    Angiogenic Factor Expression During Fractionated Irradiation (NCT02072720)
    Phase 1
    Amsterdam UMC, location VUmc
    Unknown status
    Last update posted :
    10/02/2019
    Initiation :
    02/01/2014
    Primary completion :
    03/01/2021
    Completion :
    05/01/2021
    KDR • CD31 • PECAM1
    |
    KDR expression • VEGFA expression
    |
    Avastin (bevacizumab)
    A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas (NCT01782313)
    Phase 2
    Northwestern University
    Completed
    Last update posted :
    09/09/2019
    Initiation :
    03/06/2013
    Primary completion :
    05/27/2015
    Completion :
    12/28/2016
    KDR • FLT1
    |
    KDR expression • FLT1 expression
    |
    Fotivda (tivozanib)
    A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy (NCT01364012)
    Phase 3
    Hoffmann-La Roche
    Completed
    Last update posted :
    02/05/2018
    Initiation :
    05/23/2011
    Primary completion :
    01/27/2013
    Completion :
    08/17/2017
    KDR • VEGFA
    |
    KDR expression
    |
    Avastin (bevacizumab) • carboplatin • paclitaxel
    The Osteosarcoma Biobank in Peking University People's Hospital (NCT03362086)
    Phase N/A
    Peking University People's Hospital
    Not yet recruiting
    Last update posted :
    12/05/2017
    Initiation :
    02/01/2018
    Primary completion :
    02/01/2021
    Completion :
    02/01/2024
    PD-L1 • KDR
    |
    PD-L1 expression • KDR expression